Aurobindo, Glenmark and Zydus recall products in the US market
All three Indian pharma companies have initiated the recall due to quality concerns.
15 December, 2024•2 min
0
15 December, 2024•2 min
0
More in Business
Business
Devi Shetty’s contrarian bet in expanding to the United Kingdom
On the surface, Narayana Health’s latest acquisition holds promise. But a closer look suggests that the UK’s Practice Plus Group will need a bit of a turnaround before it can start yielding results.
You may also like
Business
What the $1 trillion pledge got MBS in return
The crown prince of Saudi Arabia returns to Washington DC with big promises, but may be walking away with more.
Business
Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
